Khandelwal Laboratories Private Limited
Indian Pharmaceutical Exporter ยท Advanced Oncology Specialist ยท $1.6M Total Trade ยท DGFT Verified
Khandelwal Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.6M across 8 products in 3 therapeutic categories. Based on 241 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Tamoxifen ($742.7K), Methotrexate ($248.1K), Letrozole ($176.8K).
Khandelwal Laboratories Private Limited โ Export Portfolio & Destination Treemap

Who is Khandelwal Laboratories Private Limited? โ Company Overview & Market Position
Khandelwal Laboratories Private Limited (KLab) is a privately held pharmaceutical company established in 1945, headquartered in Mumbai, Maharashtra, India. The company specializes in the research and development, manufacturing, distribution, marketing, and licensing of patented pharmaceutical formulations, novel drug delivery systems (NDDS), niche active pharmaceutical ingredients (APIs), and chiral intermediates. KLab has a significant presence in the Indian market, particularly in oncology, antibiotics, pain, and spasm management sectors.
As of the latest available data, KLab's authorized and paid-up capital stands at โน50 million (approximately $625,000 USD). The company employs over 1,000 individuals across its operations. Its registered office is located at 79/87 D. Lad Path, Kala Chowkie, Mumbai, Maharashtra, 400033, India.